- Home
- NEOV vs ALEC Comparison
NEOV vs ALEC Comparison
Compare NEOV & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEOV | ALEC |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 143.8M | 124.0M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | NEOV | ALEC |
|---|---|---|
| Price | $4.04 | $1.32 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 9 |
| Target Price | N/A | ★ $3.40 |
| AVG Volume (30 Days) | 336.9K | ★ 1.8M |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $14,486,857.00 | ★ $69,048,000.00 |
| Revenue This Year | $91.25 | N/A |
| Revenue Next Year | $30.38 | $314.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 486.23 | 12.26 |
| 52 Week Low | $1.80 | $0.87 |
| 52 Week High | $6.19 | $3.40 |
Technical Indicators
Market Signals| Indicator | NEOV | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 44.49 | 38.78 |
| Support Level | $3.56 | $1.16 |
| Resistance Level | $5.30 | $1.39 |
| Average True Range (ATR) | 0.43 | 0.12 |
| MACD | -0.08 | 0.06 |
| Stochastic Oscillator | 29.31 | 35.23 |
Price Performance
Historical ComparisonAbout NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.